Axogen, Inc.
38.06USD
+1.3800 (+3.76%)
Not enough data yet
A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.
Sign in to share your take on AXGN.
Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.
| Period | Consensus EPS | 90 days ago | Revisions up (30d) | Revisions down (30d) |
|---|---|---|---|---|
| Current quarter | $0.13▼ | $0.14 | 1 | 1 |
| Next quarter | $0.13▼ | $0.15 | 0 | 4 |
| Current year | $0.47▼ | $0.49 | 1 | 3 |
| Next year | $0.73▲ | $0.72 | 2 | 2 |
Beat in 2 of the last 4
| Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-06-30 | $0.12 | $0.12 | +0.00 (+1.2%) |
| 2026-03-31 | $0.07 | $0.07 | -0.00 (-2.0%) |
| 2025-12-31 | $0.1 | $0.07 | -0.03 (-27.9%) |
| 2025-09-30 | $0.07 | $0.12 | +0.05 (+76.5%) |
76 ratings from 23 firms
Ratings are attributed to the research firm, not to individual analysts. See every ticker.
| Firm | Action | Rating | Price Target | Date |
|---|---|---|---|---|
| Barclays | Maintained | Overweight | $55 $50 | Oct 23, 2026 |
| B of A Securities | Initiated | Buy | $52 | Oct 12, 2026 |
| Barclays | Initiated | Overweight | $55 | Oct 7, 2026 |
| Truist Securities | Maintained | Buy | $60 $53 | Oct 1, 2026 |
| Raymond James | Maintained | Outperform | $48 $53 | Sep 25, 2026 |
| Truist Securities | Initiated | Buy | $60 | Aug 26, 2026 |
| Canaccord Genuity | Maintained | Buy | $50 $55 | Jul 30, 2026 |
| Citizens | Maintained | Market Outperform | $50 $55 | Jul 30, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $50 $53 | Jul 30, 2026 |
| Canaccord Genuity | Maintained | Buy | $45 $50 | Apr 29, 2026 |
| Citizens | Maintained | Market Outperform | $42 $50 | Apr 29, 2026 |
| Wells Fargo | Maintained | Overweight | $40 $48 | Apr 29, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $39 $50 | Apr 29, 2026 |
| Lake Street | Maintained | Buy | $40 $50 | Apr 23, 2026 |
| Canaccord Genuity | Maintained | Buy | $40 | Mar 30, 2026 |
| Citizens | Maintained | Market Outperform | $34 $42 | Feb 24, 2026 |
| Wells Fargo | Initiated | Overweight | $40 | Feb 19, 2026 |
| Canaccord Genuity | Maintained | Buy | $27 $37 | Dec 5, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $26 $39 | Dec 5, 2025 |
| Jefferies | Maintained | Buy | $29 $36 | Dec 4, 2025 |
| Lake Street | Maintained | Buy | $30 $40 | Dec 4, 2025 |
| Mizuho | Initiated | Outperform | $40 | Dec 1, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $25 $26 | Oct 30, 2025 |
| Raymond James | Maintained | Outperform | $20 $27 | Oct 30, 2025 |
| Canaccord Genuity | Maintained | Buy | $24 $27 | Oct 30, 2025 |
87 filings from 14 insiders · 13 buy / 10 sell over 6m
Officers and directors of AXGN, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.
| Insider | Action | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| TYNDALL JOSEPH ADirector | Sell | 3.5k | $49.70 | $174k | Sep 2, 2026 |
| MCBRIDE-WENDELL AMY A.Director | Exercise | 13.4k | $14.85 | $198k | Aug 11, 2026 |
| MCBRIDE-WENDELL AMY A.Director | Sell | 13.4k | $48.42 | $647k | Aug 11, 2026 |
| BEGAN MARC A.General Counsel | Exercise | 67.5k | $8.16 | $551k | Aug 10, 2026 |
| BEGAN MARC A.General Counsel | Sell | 67.5k | $47.34 | $3.20M | Aug 10, 2026 |
| WEILER KATHY JOHNSONDirector | Sell | 14.2k | $45.30 | $641k | Aug 7, 2026 |
| MCBRIDE-WENDELL AMY A.Director | Other | 14.2k | — | — | Jun 18, 2026 |
| THOMAS PAUL GDirector | Other | 18.9k | — | — | Jun 18, 2026 |
| WEILER KATHY JOHNSONDirector | Other | 14.2k | — | — | Jun 18, 2026 |
| TYNDALL JOSEPH ADirector | Other | 14.2k | — | — | Jun 18, 2026 |
| LEVINE ALAN M.Director | Other | 14.2k | — | — | Jun 18, 2026 |
| BURKE WILLIAM P.Director | Other | 14.2k | — | — | Jun 18, 2026 |
| JOHNSON JOHN H.Director | Other | 14.2k | — | — | Jun 18, 2026 |
| MCBRIDE-WENDELL AMY A.Director | Exercise | 1.6k | $14.85 | $24k | May 8, 2026 |
| MCBRIDE-WENDELL AMY A.Director | Sell | 1.6k | $42.60 | $70k | May 8, 2026 |
| HARTLEY LINDSEY MARIEChief Financial Officer | Exercise | 5.5k | $8.20 | $45k | May 7, 2026 |
| WEILER KATHY JOHNSONDirector | Exercise | 16.3k | $6.95 | $114k | May 7, 2026 |
| JOHNSON JOHN H.Director | Exercise | 11.1k | $7.04 | $78k | May 7, 2026 |
| QUACKENBUSH DORISOfficer | Sell | 3.9k | $43.51 | $169k | May 7, 2026 |
| HARTLEY LINDSEY MARIEChief Financial Officer | Sell | 1.1k | $43.67 | $46k | May 7, 2026 |
No analyst notes on AXGN yet.
Analyst Ratings
11 analysts covering
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Consensus |
|---|---|---|---|---|---|---|
| Current | 2 | 9 | 0 | 0 | 0 | Buy1.82 |
| 1 mo ago | 2 | 8 | 0 | 0 | 0 | Buy1.80 |
| 2 mo ago | 2 | 8 | 0 | 0 | 0 | Buy1.80 |
| 3 mo ago | 2 | 7 | 0 | 0 | 0 | Buy1.78 |
Members whose judged calls on AXGN have played out most reliably.
No settled calls on AXGN yet. Nobody has filed a call with a deadline on it.
A member is listed once they have three judged calls on a name.
A call with a target is judged on whether the price reaches it by the deadline, counting each day's high (a buy) or low (a sell) from the day after the call was made. A call without one is judged on whether the price at the close on the deadline is higher (a buy) or lower (a sell) than the price the call was made at: the live price when it was saved, for a call made with Make a call, or the last close before the day it was filed, for a call made in a note. Not against the market or an index.
A percentage appears once five calls have reached their deadline. A target reached sooner is shown as played out early, and counts toward the percentage when its deadline passes, because a miss cannot be known before then.
A member’s prediction, judged on price history · not investment advice